10 years of tamoxifen better to prevent breast cancer, study finds

Women using tamoxifen to prevent a recurrence of breast cancer had better protection if they took the drug for 10 years instead of the standard five, Oxford University researchers reported in The Lancet. Breast cancer experts said the data, which showed a lower recurrence rate among women who took the drug longer, also may have implications for postmenopausal women who usually take other medications to prevent a recurrence.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID